These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 28011488

  • 21. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
    van den Bosch T, Koopmans AE, Vaarwater J, van den Berg M, de Klein A, Verdijk RM.
    Invest Ophthalmol Vis Sci; 2013 Nov 08; 54(12):7354-61. PubMed ID: 24052640
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J, Deng X, Bian X, Li G, Tong Y, Li Y, Wang Q, Xin R, He X, Zhou G, Xie P, Li Y, Wang JM, Cao Y.
    Clin Cancer Res; 2005 Jul 01; 11(13):4658-65. PubMed ID: 16000558
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
    Na IK, Scheibenbogen C, Adam C, Stroux A, Ghadjar P, Thiel E, Keilholz U, Coupland SE.
    Hum Pathol; 2008 Dec 01; 39(12):1751-5. PubMed ID: 18701133
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
    Yopp AC, Shia J, Butte JM, Allen PJ, Fong Y, Jarnagin WR, DeMatteo RP, D'Angelica MI.
    Ann Surg Oncol; 2012 Jul 01; 19 Suppl 3():S339-46. PubMed ID: 21584832
    [Abstract] [Full Text] [Related]

  • 28. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.
    Pathol Res Pract; 2008 Jul 01; 204(6):379-87. PubMed ID: 18343598
    [Abstract] [Full Text] [Related]

  • 29. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
    Li X, Sun S, Li N, Gao J, Yu J, Zhao J, Li M, Zhao Z.
    Cell Physiol Biochem; 2017 Jul 01; 43(2):531-539. PubMed ID: 28930757
    [Abstract] [Full Text] [Related]

  • 30. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis.
    Takanami I.
    Int J Cancer; 2003 Jun 10; 105(2):186-9. PubMed ID: 12673677
    [Abstract] [Full Text] [Related]

  • 31. HtrA1 loss is related to aggressive behavior parameters in sentinel node positive breast cancer.
    Franco R, Collina F, Di Bonito M, Botti G, Montanaro D, Di Maio L, Vincenzi B, Landi G, D'Aiuto M, Caraglia M, Baldi A.
    Histol Histopathol; 2015 Jun 10; 30(6):707-14. PubMed ID: 25530301
    [Abstract] [Full Text] [Related]

  • 32. Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer.
    Chen HW, Du CW, Wei XL, Khoo US, Zhang GJ.
    Curr Mol Med; 2013 Mar 10; 13(3):410-6. PubMed ID: 23331013
    [Abstract] [Full Text] [Related]

  • 33. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
    Shim H, Lau SK, Devi S, Yoon Y, Cho HT, Liang Z.
    Biochem Biophys Res Commun; 2006 Jul 21; 346(1):252-8. PubMed ID: 16756955
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status.
    Stark AM, Schem C, Maass N, Hugo HH, Jonat W, Mehdorn HM, Held-Feindt J.
    Neurol Res; 2010 Apr 21; 32(3):303-8. PubMed ID: 19909580
    [Abstract] [Full Text] [Related]

  • 36. Outcome in breast molecular subtypes according to nodal status and surgical procedures.
    Mazouni C, Rimareix F, Mathieu MC, Uzan C, Bourgier C, André F, Delaloge S, Garbay JR.
    Am J Surg; 2013 Jun 21; 205(6):662-7. PubMed ID: 23312273
    [Abstract] [Full Text] [Related]

  • 37. [Tumor infiltrating regulatory T cells in human breast cancer and associated draining lymph nodes: an in-situ analysis].
    Wang HY, Shi QF, Sun Y, He JJ, Wang YL.
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb 21; 42(2):95-100. PubMed ID: 23710915
    [Abstract] [Full Text] [Related]

  • 38. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM, Bone ND, Stenson MJ, Novak A, Hedin KE, Kay NE, Ansell SM.
    Mayo Clin Proc; 2004 Mar 21; 79(3):318-25. PubMed ID: 15008605
    [Abstract] [Full Text] [Related]

  • 39. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G, Classe JM, Garbay JR, Giard S, Cohen M, Faure C, Charytansky H, Rouzier R, Daraï E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Fraisse J, Dravet F, Chauvet MP, Goncalves A, Lambaudie E.
    Eur J Cancer; 2016 May 21; 58():73-82. PubMed ID: 26971077
    [Abstract] [Full Text] [Related]

  • 40. Concordance between HER-2 and steroid hormone receptor expression between primary breast cancer, sentinel node metastases, and isolated tumor cells.
    Strien L, Leidenius M, von Smitten K, Heikkilä P.
    Pathol Res Pract; 2010 Apr 15; 206(4):253-8. PubMed ID: 20138441
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.